30
May
2023
From Structural Biology to Structuring Companies: Deb Palestrant on The Long Run
Today’s guest on The Long Run is Deb Palestrant. Deb is a partner with 5AM Ventures and the executive chair of the 4:59 Initiative. 5AM invests in early-stage startups working on a variety of novel biological targets and some of the emerging new treatment modalities – gene therapy, gene editing, oligonucleotides. As the name suggests, it’s not afraid to get... Read More